Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute.
This study reviews the clinical manifestations, causes and frequency of Stomatococcus mucilaginosus bacteremia in neutropenic cancer patients. We analyzed retrospectively all clinical and microbiological records of patients with S. mucilaginosus bacteremia. The incidence was compared with that of other pathogens causing bacteremia during neutropenia for the same period. S. mucilaginosus represented 5.9% of bacteremias in our neutropenic patients. Seven patients with hematologic malignancies and one with breast cancer are described. The common clinical presentation was one of sepsis. All patients presented with damaged mucosal barriers as the probable portal of entry, from either stomatitis or enterocolitis. All patients survived.
Fanourgiakis
P
P
Laboratoire de Microbiologie et Département des Maladies Infectieuses, Institut Jules Bordet, rue Héger-Bordet 1, 1000 Bruxelles, Belgium.
Georgala
A
A
Vekemans
M
M
Daneau
D
D
Heymans
C
C
Aoun
M
M
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications* / Q000382:microbiology; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008297:Male; D008835:Micrococcaceae / Q000302:isolation & purification*; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications*; D012189:Retrospective Studies
D000890:Anti-Infective Agents